Outcomes of Patients with Therapy-Related Myelodysplastic Syndromes (MDS) after Chemoimmunotherapy for Chronic Lymphocytic Leukemia Compared to Patients with De Novo MDS: A Single-Institution Experience
ConclusionHistory of CLL did not independently impact OS in t-MDS patients beyond IPSS-R.
Source: Clinical Lymphoma Myeloma and Leukemia - Category: Cancer & Oncology Source Type: research
More News: Cancer & Oncology | Carisoprodol | Chronic Leukemia | Chronic Lymphocytic Leukemia | Leukemia | Lymphoma | Myelodysplastic Syndrome | Myeloma | Rituxan | Soma